MTOR and cancer: Altered regulation of the RAS/MAPK and PI3K/AKT/mTOR pathways are e.g. associated with autism and other neurodevelopmental disorders, and with the development of cancer [29–31] and alterations in these pathways are also involved in the development of TGCT [32, 33].